Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study
- 1 May 2003
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 125 (5) , 1121-1131
- https://doi.org/10.1067/mtc.2003.176
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemopreventionCarcinogenesis: Integrative Cancer Research, 2001
- Molecular Biology of Barrett’s AdenocarcinomaAnnals of Surgery, 2001
- Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the EsophagusThe American Journal of Pathology, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- The p53 pathwayThe Journal of Pathology, 1999
- Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer, 1998
- IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation toolsNucleic Acids Research, 1998
- Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardiaJNCI Journal of the National Cancer Institute, 1997
- Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A reviewInternational Journal of Cancer, 1996
- The rising trend in oesophageal adenocarcinoma and gastric cardiaEuropean Journal Of Cancer Prevention, 1992